Biotech is a hard game and (IMO) the only area $$$ has remained on the sidelines since the GFC.Even speccy mineral explorers get more interest these days which is a shame really considering the potential.
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
